
Am J Psychiatry 163:1826-1829, October 2006
doi: 10.1176/appi.ajp.163.10.1826
© 2006 American Psychiatric Association
Effect of 5-HT1A Receptor Gene Polymorphism on Negative and Depressive Symptom Response to Antipsychotic Treatment of Drug-Naive Psychotic Patients
Gavin P. Reynolds, Ph.D.,
Belen Arranz, M.D., Ph.D.,
Lucy A. Templeman, Ph.D.,
Sofia Fertuzinhos, B.S., and
Luis San, M.D., Ph.D.
OBJECTIVE: The serotonin 5-HT1A receptor may modulate some of the negative, cognitive, and affective symptoms of schizophrenia and is a potential target of action of some antipsychotic drugs. A functional polymorphism in the promoter region of the 5-HT1A receptor gene is associated with depression and suicidal behavior. The authors sought to determine whether this polymorphism influences symptom response to antipsychotic drug treatment. METHOD: Sixty-three drug-naive patients with first-episode psychosis who were genotyped for the 1019C/G polymorphism were recruited for this study and received standard care. The Positive and Negative Syndrome Scale and the Calgary Depression Scale were used to monitor symptom changes over 3 months. RESULTS: The polymorphism was associated with, and accounted for much of the variance in, changes in negative and depressive symptoms but not positive symptoms. CONCLUSIONS: These findings identify an important genetic factor predicting much of the response in negative and depressive symptoms to antipsychotic drug treatment.
Related Article:
-
In This Issue
Am J Psychiatry 2006 163: A62.
[Full Text]
[PDF]
Get information about faster international access.
a>
Privacy Policy
Copyright © 2006
American Psychiatric Association.
All rights reserved.
Home
| Search
| Current Issue
| Past Issues
| Subscribe
| All APPI Journals
| Help
| Contact Us
|